Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Swaroop Kumar Pandey

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Current Molecular Medicine|January 23, 2026
Phosphatidylethanolamine: Structural Component and BeyondSwaroop Kumar Pandey, Ayush Kulshreshtha, Anuja Mishra
Journal of Microbiological Methods|April 28, 2026
Integrating microbial bioremediation, multi-omics, and emerging technologies for polycyclic aromatic hydrocarbon (PAHs) detoxificationShruti Khandelwal, Anuja Mishra, Swaroop Kumar Pandey
Current Cancer Drug Targets|June 8, 2026
Targeting Drug Metabolism for Triple Negative Breast Cancer: A Systematic ReviewSakshi Singh, Swaroop Kumar Pandey, Jagdip Singh Sohal
Advances in Medicine|March 24, 2023
Drug Development Strategies for Malaria: With the Hope for New Antimalarial Drug Discovery-An UpdateSwaroop Kumar Pandey, Uttpal Anand, Waseem A Siddiqui, et al.
Chemical Biology & Drug Design|June 9, 2021
Synergistic interaction of N-3-Br-benzyl-noscapine and docetaxel abrogates oncogenic potential of breast cancer cellsShruti Gamya Dash, Srinivas Kantevari, Swaroop Kumar Pandey, et al.
Parasitology|November 10, 2012
Antimalarial interaction of quinine and quinidine with clarithromycinSwaroop Kumar Pandey, Hemlata Dwivedi, Sarika Singh, et al.
Acta Tropica|February 9, 2013
Ketoconazole, a cytochrome P(450) inhibitor can potentiate the antimalarial action of α/β arteether against MDR Plasmodium yoelii nigeriensisRenu Tripathi, Amber Rizvi, Swaroop Kumar Pandey, et al.
Frontiers in Oncology|October 3, 2022
Non-apoptotic activity of the mitochondrial protein SMAC/Diablo in lung cancer: Novel target to disrupt survival, inflammation, and immunosuppressionSwaroop Kumar Pandey, Anna Shteinfer-Kuzmine, Vered Chalifa-Caspi, et al.
Cells|April 12, 2024
Silencing the Mitochondrial Gatekeeper VDAC1 as a Potential Treatment for Bladder CancerBelal Alhozeel, Swaroop Kumar Pandey, Anna Shteinfer-Kuzmine, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|June 4, 2024
Androgen Signaling in Prostate Cancer: When a Friend Turns FoeSwaroop Kumar Pandey, Usha Sabharwal, Swati Tripathi, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Current Molecular Medicine|January 23, 2026
Phosphatidylethanolamine: Structural Component and BeyondSwaroop Kumar Pandey, Ayush Kulshreshtha, Anuja Mishra
Journal of Microbiological Methods|April 28, 2026
Integrating microbial bioremediation, multi-omics, and emerging technologies for polycyclic aromatic hydrocarbon (PAHs) detoxificationShruti Khandelwal, Anuja Mishra, Swaroop Kumar Pandey
Current Cancer Drug Targets|June 8, 2026
Targeting Drug Metabolism for Triple Negative Breast Cancer: A Systematic ReviewSakshi Singh, Swaroop Kumar Pandey, Jagdip Singh Sohal
Advances in Medicine|March 24, 2023
Drug Development Strategies for Malaria: With the Hope for New Antimalarial Drug Discovery-An UpdateSwaroop Kumar Pandey, Uttpal Anand, Waseem A Siddiqui, et al.
Chemical Biology & Drug Design|June 9, 2021
Synergistic interaction of N-3-Br-benzyl-noscapine and docetaxel abrogates oncogenic potential of breast cancer cellsShruti Gamya Dash, Srinivas Kantevari, Swaroop Kumar Pandey, et al.
Parasitology|November 10, 2012
Antimalarial interaction of quinine and quinidine with clarithromycinSwaroop Kumar Pandey, Hemlata Dwivedi, Sarika Singh, et al.
Acta Tropica|February 9, 2013
Ketoconazole, a cytochrome P(450) inhibitor can potentiate the antimalarial action of α/β arteether against MDR Plasmodium yoelii nigeriensisRenu Tripathi, Amber Rizvi, Swaroop Kumar Pandey, et al.
Frontiers in Oncology|October 3, 2022
Non-apoptotic activity of the mitochondrial protein SMAC/Diablo in lung cancer: Novel target to disrupt survival, inflammation, and immunosuppressionSwaroop Kumar Pandey, Anna Shteinfer-Kuzmine, Vered Chalifa-Caspi, et al.
Cells|April 12, 2024
Silencing the Mitochondrial Gatekeeper VDAC1 as a Potential Treatment for Bladder CancerBelal Alhozeel, Swaroop Kumar Pandey, Anna Shteinfer-Kuzmine, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|June 4, 2024
Androgen Signaling in Prostate Cancer: When a Friend Turns FoeSwaroop Kumar Pandey, Usha Sabharwal, Swati Tripathi, et al.
Pageof 4